Blinatumomab only product in parenteral dose form
|
Product containing precisely blinatumomab 38.5 microgram/1 vial powder for conventional release solution for infusion (clinical drug)
Blinatumomab 38.5 microgram powder for solution for infusion vial
Id1201800000
StatusDefined
Has manufactured dose formPowder for solution for infusion
Has unit of presentationVial
Plays roleAntineoplastic therapeutic role
Has BoSSBlinatumomab
Has precise active ingredientBlinatumomab
Has presentation strength denominator unitVial
Has presentation strength numerator unitmcg